Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
-
2025 Best of HR Services™ Award Winners Achieve Superior Ratings for Client Experience
-
2025 Best of Insurance™ Award Winners Achieve Superior Ratings for Client Experience
-
2025 Best of Accounting™ Award Winners Achieve Superior Ratings for Client and Employee Experience
-
2025 Best of Staffing® Award Winners Achieve Superior Ratings for Client, Talent, and Employee Experience
-
2025 Best of IT Services™ Award Winners Achieve Superior Ratings for Client and Employee Experience
-
Harvia Plc: Disclosure under chapter 9, section 10 of the securities market act
-
Lassila & Tikanoja plc: Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act
-
Aqua Metals Expands Vision for Commercial Giga-Scale Lithium Battery Recycling – More than Doubling the Output of Battery Grade Lithium at Sierra ARC Phase 1
-
Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America
-
Intuitive Machines Announces Redemption of Outstanding Warrants
-
Novo Nordisk A/S - share repurchase programme
-
Fengate expands retirement community portfolio with the acquisition of two new properties in British Columbia
-
250 by 2050: Cultivating more million-dollar companies in Saskatchewan
-
Middlefield Canadian Income PCC - Holding(s) in Company
-
IES Holdings Reports Fiscal 2025 First Quarter Results
-
Applied Materials Awards Suppliers for Outstanding Performance
-
Sensei Biotherapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
-
Tornado Infrastructure Equipment Launches Tornado Equipment Finance, Provides Q4/2024 Business Update and Implements Tariff Mitigation Strategies
-
Global Crossing Airlines to Achieve High End of its Fourth Quarter & Full Year 2024 Guidance; Provides Operational Updates
-
AYR Wellness to Hold Fourth Quarter and Full Year 2024 Conference Call on March 6 at 8:30 a.m. ET
-
I-Mab to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
-
Quoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure
-
Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial
-
USA Rare Earth and Inflection Point Acquisition Corp. II Announce Upsized PIPE
-
ZenaTech Signes LOI to Acquire a Fifth Land Survey Company; Focused on Assisting Border Patrol and Law Enforcement to Control Illegal Immigration
-
Red Pine Drilling Expands Gold System at Wawa Gold Project
-
Hubbell Reports Fourth Quarter 2024 and Full Year Results
-
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
Uvax Bio Appoints Kevin O’Neill as Interim Chief Executive Officer
-
Bread Financial to Participate in the BofA Securities 2025 Financial Services Conference
-
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
-
Avante Provides Corporate Update on Launch of Avante Verified in the U.S. to Revolutionize School Safety and Confirms Minimal Impact from U.S. Tariffs
-
Charging Robotics: Revoltz Receives Israeli Standards Institute Approval for PORTO EV Micro Vehicle
-
Construction contract (Viljandi spa hotel)
-
Coloplast A/S - Allocation of Share Options
-
Clearside Biomedical to Participate in Fireside Chat at the Oppenheimer 35th Annual Healthcare Life Sciences Virtual Conference
-
Ingredion Invests $100 Million in Indianapolis Plant to Improve Efficiency and Enable Future Texture Solutions Growth
-
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
-
Navatar’s A-Game Podcast: How Left Lane Associates Beats Top Investment Banks Like Goldman Sachs to Dominate Supply Chain M&A
-
Alliance Witan PLC - Net Asset Value
-
Navatar’s A-Game Podcast: How Left Lane Associates Beats Top Investment Banks Like Goldman Sachs to Dominate Supply Chain M&A
-
ONL Therapeutics Announces Multiple Presentations at Leading Ophthalmology Meetings
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
NGM Bio Announces Appointment of Wendy Yeh, M.D. as Chief Medical Officer
-
Troilus Initiates Drilling and Advanced Geophysical Surveys as Part of Its 2025 Exploration Program
-
Aya Gold & Silver Expands Boumadine Footprint, Adding 4 Mining Licences and a 600 km² Exploration Authorization
-
Xtract One Accelerating Growth with New Distributor Velasea
-
Nurix Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
